[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Physicochemical and Structural (Q3) Characterization of Top...[ Price : $8.95]
Janssen Pharmaceutical says new data show that patients given Tremfya (guselkumab) saw a clinical response rate of about 80% in tr...[ Price : $8.95]
Responding to a petition seeking the removal of approval for Jazz Pharmaceuticals lung cancer drug Zepzelca, FDA explains why it d...[ Price : $8.95]
FDA gives accelerated approval to Janssens teclistamab-cqyv for some adults with relapsed or refractory multiple myeloma.[ Price : $8.95]
FDA medical reviewers tell members of the Cardiovascular and Renal Drugs Advisory Committee there are safety concerns with GlaxoSm...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled In Vitro Release Test Studies for Topical Products Submitte...[ Price : $8.95]
Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances for developing topical ...[ Price : $8.95]
FDA determines there are insufficient data to support a proposed cefazolin susceptible minimum inhibitory concentration breakpoint...